Demographic and health factors associated with enrollment in posttrial studies: The women’s health initiative hormone therapy trials.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Works matching IS 17407745 AND DT 2013 AND VI 10 AND IP 3
Results: 18
1
2
Clinician-trialist rounds: 16. Mind your explanatory and pragmatic attitudes! – part 1: what?
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
3
Summarizing the incidence of adverse events using volcano plots and time intervals.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 398, doi. 10.1177/1740774513485311
- By:
- Publication type:
- Article
4
Clinician-trialist rounds: 16. Mind your explanatory and pragmatic attitudes! – part 1: what?
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 495, doi. 10.1177/1740774513484395
- By:
- Publication type:
- Article
5
Adaptive adjustment of the randomization ratio using historical control data.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 430, doi. 10.1177/1740774513483934
- By:
- Publication type:
- Article
6
Preserving participant anonymity during remote preenrollment consent form checking.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 460, doi. 10.1177/1740774513480962
- By:
- Publication type:
- Article
7
Early phase trial design for assessing several dose levels for toxicity and efficacy for targeted agents.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 422, doi. 10.1177/1740774513480961
- By:
- Publication type:
- Article
8
Parent perspectives on consent for the linkage of data to evaluate vaccine safety: A randomised trial of opt-in and opt-out consent.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 483, doi. 10.1177/1740774513480568
- By:
- Publication type:
- Article
9
Remote preenrollment checking of consent forms to reduce nonconformity.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 449, doi. 10.1177/1740774513480003
- By:
- Publication type:
- Article
10
Accommodating missingness when assessing surrogacy via principal stratification.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 363, doi. 10.1177/1740774513479522
- By:
- Publication type:
- Article
11
Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: An empirical assessment.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 389, doi. 10.1177/1740774513479467
- By:
- Publication type:
- Article
12
Evaluating and utilizing probability of study success in clinical development.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 407, doi. 10.1177/1740774513478229
- By:
- Publication type:
- Article
13
Demographic and health factors associated with enrollment in posttrial studies: The women’s health initiative hormone therapy trials.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 463, doi. 10.1177/1740774513477931
- By:
- Publication type:
- Article
14
Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 378, doi. 10.1177/1740774512470317
- By:
- Publication type:
- Article
15
Bayesian adaptive phase II screening design for combination trials.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 353, doi. 10.1177/1740774512470316
- By:
- Publication type:
- Article
16
Recruiting a special sample with sparse resources: Lessons from a study of Gulf War veterans.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 473, doi. 10.1177/1740774512470040
- By:
- Publication type:
- Article
17
Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 414, doi. 10.1177/1740774511411593
- By:
- Publication type:
- Article
18
Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments.
- Published in:
- Clinical Trials, 2013, v. 10, n. 3, p. 441, doi. 10.1177/1740774511410331
- By:
- Publication type:
- Article